Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmaniaga BhdXKLS:7081 45 Median PS Value is RM1.32 as of Jul. 18, 2026, which is 100% below its 10-year median of 0.40. GuruFocus rates XKLS:7081 with a GF Score™ of 45/100 and a GF Value™ of RM0.73 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 70 Medical Distribution companies, Pharmaniaga Bhd ranks worse than 58.57% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
As of today (2026-07-18), Pharmaniaga Bhd's share price is RM1.18. Pharmaniaga Bhd's Median PS Value is RM1.32. Therefore, Pharmaniaga Bhd's Price to Median PS Value for today is 0.89.
The historical rank and industry rank for Pharmaniaga Bhd's Median PS Value or its related term are showing as below:
XKLS:7081'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.2 Med: 0.4 Max: 0.93
Current: 0.89
During the past 13 years, the highest Price to Median PS Value of Pharmaniaga Bhd was 0.93. The lowest was 0.20. And the median was 0.40.
XKLS:7081's Price-to-Median-PS-Value is ranked worse than 58.57% of 70
companies
in the Medical Distribution industry
Industry Median: 0.85
vs XKLS:7081: 0.89
Pharmaniaga Bhd (XKLS:7081) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Pharmaniaga Bhd's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
1.18
/
1.32
=
0.89
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd Median PS Value Related Terms
Pharmaniaga Bhd Median PS Value Historical Data
* Premium members only.
The historical data trend for Pharmaniaga Bhd's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7081 vs MCK, CAH, COR: Median PS Value Comparison
For the Medical Distribution subindustry, Pharmaniaga Bhd's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd Price-to-Median-PS-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.2189.
Pharmaniaga Bhd's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM6.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a Median PS Value of RM1.32 as of Jul. 18, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Pharmaniaga Bhd and its competitors. This is 230% above median its historical median of 0.40. Over the past decade, Pharmaniaga Bhd's Median PS Value has ranged from 0.20 to 0.93. According to the industry distribution chart, Pharmaniaga Bhd ranks #41 out of 70 companies in the Medical Distribution industry, placing it in the top 58.6%.
Is Pharmaniaga Bhd's Median PS Value too high?
Pharmaniaga Bhd's current Median PS Value of RM1.32 is 230% above median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 0.93. Based on the distribution chart, Pharmaniaga Bhd ranks #41 out of 70 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Pharmaniaga Bhd has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Median PS Value compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Pharmaniaga Bhd ranks #41 out of 70 companies for Median PS Value. This places Pharmaniaga Bhd in the lower half of its industry. The industry median Median PS Value is 0.85. Historically, Pharmaniaga Bhd's own Median PS Value has ranged from 0.20 to 0.93 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Distribution company?
The median Median PS Value among Medical Distribution companies is 0.85, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Pharmaniaga Bhd and its competitors. For the Medical Distribution industry, the median Median PS Value is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaniaga Bhd's current Median PS Value is RM1.32, which is 230% above median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.73, compared to a current price of RM1.18 — trading 61.6% above its estimated fair value. The current Median PS Value is RM1.32, which is 230% above median its 10-year median of 0.40. Pharmaniaga Bhd's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Median PS Value is RM1.32 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.18 is trading 61.6% above its estimated GF Value™ of RM0.73.
GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:7081:
Median PS Value: RM1.32 (230% above median its 10-year median of 0.40)
GF Value™: RM0.73 vs. price of RM1.18 (61.6% above fair value)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
45GF Score
Get the complete analysis for XKLS:7081
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
